Answer
Brodalumab is a monoclonal antibody that binds to IL-17RA, blocking the activity of inflammatory cytokines IL-17A, IL-17F, IL-17A/F, IL-17C and IL-17E, thereby inhibiting inflammation and symptoms associated with psoriasis.
Sources for this answer
- Kyntheum 210 mg Solution for InjectionLeo Laboratories Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 7Document updated
Sources checked